CCL5 and hepatocellular carcinoma: Consistent with our observations, CCL5 and CXCL10 are reported to recruit antitumor CD8+ T lymphocytes into malignancies and are positively associated with the survival of patients with colorectal cancer or hepatocellular carcinoma [30, 37].